Ignite Creation Date:
2024-05-06 @ 10:58 AM
Last Modification Date:
2024-10-26 @ 12:38 PM
Study NCT ID:
NCT03392909
Status:
RECRUITING
Last Update Posted:
2022-11-03
First Post:
2018-01-02
Brief Title:
Intravenous Gentamicin Therapy for Recessive Dystrophic Epidermolysis Bullosa RDEB
Sponsor:
University of Southern California
Organization:
University of Southern California
Organization Data
Organization:
University of Southern California
Class:
OTHER
Study ID:
HS-17-00995
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Southern California
Lead Sponsor Class:
OTHER
Responsible Party:
David Woodley
Responsible Party Title:
Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
University of Southern California
Old Name:
None
Old Organization:
None